Lighteum Medical appoints Gaurav Agarwal as CEO

Lighteum Medical, San Diego, California, a manufacturer of precision medical components including high-complexity nitinol-based solutions, appointed Gaurav Agarwal as chief executive officer.

Agarwal has nearly 30 years of leadership experience across medical devices, diagnostics, and healthcare technology, including involvement in more than $15 billion in M&A transactions and $11 billion in private equity dispositions. He most recently served as president and CEO of Capsa Healthcare, where the company delivered more than 20% revenue and EBITDA growth in 18 months and completed two tuck-in acquisitions. He previously served as president and CEO of Vyaire Medical and held senior positions at Acelity/KCI, Smith & Nephew, and GE Healthcare. At Acelity/KCI, he led global commercial roles during the company’s $6.725 billion sale to 3M.

“Gaurav is an accomplished medtech leader and proven growth-oriented operator with a track record of building high-performing organizations and driving results,” said Gregory T. Lucier, chairman of the board.

“I am excited to join Lighteum Medical and advance our mission of providing precision-engineered solutions that enable life-enhancing, minimally invasive medical devices,” said Agarwal.

Lighteum Medical, a Montagu portfolio company, was formed by combining Medical Device Components LLC and Lighteum LLC. The company specializes in platinum group metals and nitinol components and applies expertise in metallurgy, micromachining, femtosecond laser processing, shape setting, and electropolishing. It operates manufacturing centers in San Diego and Oceanside, California; Mexicali, Mexico; and Tullamarine, Australia.

Read further here: https://qmed.com/lighteum-medical-appoints-gaurav-agarwal-as-chief-news129923.html

Axel Johnson Inc. takes full ownership of Fort Wayne Metals

Axel Johnson Inc. (AJI), New York, acquired full ownership of Fort Wayne Metals Research Products LLC, Fort Wayne, Indiana, from the Glaze family. AJI first invested in the company in 2021.

Founded in 1970, Fort Wayne Metals develops and manufactures high-performance precision materials for medical devices and other critical applications, supporting millions of medical procedures each year. The company will remain headquartered in Fort Wayne, where it has operated for more than 50 years.

Jeremy Rohrs continues as president and CEO of Fort Wayne Metals.

“Today marks the beginning of an exciting new chapter for Fort Wayne Metals and AJI,” said Sara Greenstein, CEO, Axel Johnson Inc.

“This milestone represents an exciting opportunity for our employees, customers, and partners,” said Rohrs.

The transition completes a partnership that began five years ago and places Fort Wayne Metals fully within AJI’s portfolio of long-term holdings. AJI, founded in 1920 and headquartered in New York City, is a family-owned investment company that builds businesses through long-term ownership partnerships. It employs more than 5,500 people and is part of the Axel Johnson Group, which has about 40,000 employees.

Fort Wayne Metals is a supplier of precision wire and materials to the medical device industry, with a long history of innovation and quality in materials for medical and industrial applications.

Read further here: https://www.businesswire.com/news/home/20260701588723/en/Fort-Wayne-Metals-Joins-Axel-Johnson-Inc.-in-Full-Ownership-Transition

Pressio Spine completes first cases with nitinol compression staple

Pressio Spine announced the successful completion of the first surgical cases using its Continuum compression staple, a superelastic nitinol fixation system for single-level anterior cervical discectomy and fusion (ACDF).

The Continuum staple is engineered to provide continuous compression across the fusion site. It uses an in-line spinal positioning design with a streamlined placement technique and is supplied as a fully sterile, single-use instrument kit.

The initial cases were performed by Dr. Daniel Leas of Carolina Neurosurgery and Spine Associates.

“The nitinol compression is doing real work immediately,” said Leas. “I don’t have to think about screw angles or trajectories or multi-step fixation protocols.”

Conventional anterior cervical fixation typically relies on plates and screws placed in multiple steps. Pressio Spine positions Continuum as an alternative in which the superelastic nitinol actively maintains load on the graft after placement.

“Continuum changes that entirely,” said Kent Ellington, CEO, Pressio Spine. “The nitinol compression is actively working, continuously supporting the fusion site.”

The staple is designed for use alongside the company’s Tidal cervical fusion cage, a 3D-printed titanium cage with 80% porosity and a threaded design for rotational stability.

Pressio Spine develops spine surgery technologies intended to bridge clinical potential and patient outcomes in modern operating environments.

Read further here: https://www.financialcontent.com/article/bizwire-2026-9-15-pressio-spine-announces-successful-completion-of-initial-continuum-cases

Quasar Medical acquires Nitinol Design and Development Center in San Diego

Quasar Medical, a global contract development and manufacturing organization (CDMO) for minimally invasive medical devices, acquired the Nitinol Design and Development Center in San Diego, California, from Medres International.

The 10,000-sq-ft center, established in 2024, provides nitinol design, development, process engineering, and precision manufacturing for minimally invasive devices. Its capabilities include laser cutting, shape setting, and electropolishing. The acquisition brings dedicated nitinol operations and engineering staff to Quasar and adds design, prototyping, and process optimization capabilities.

The center is about an hour’s drive from Quasar’s facility in Tecate, Mexico, and will have access to the company’s global manufacturing network of 11 locations. Integration will be overseen by Christine Trepanier, senior vice president of technology at Quasar Medical, with Tom Duerig, who introduced nitinol to medical devices as founder of NDC, serving as senior advisor.

“Nitinol is a foundational technology for many of today’s most advanced devices, both in minimally invasive disposables and implantables,” said Alex Wallstein, CEO, Quasar Medical. “This is a significant upgrade of Quasar to a whole new level of expertise.”

“We are confident that under the stewardship of Quasar, the Nitinol Center in San Diego will thrive with dramatically increased resources and customer reach to achieve its full potential,” said Dr. Chris Cheng, CEO and chairman, Medres International.

Quasar Medical has more than 38 years of experience, about 5,000 employees, and 11 locations. The ISO 13485:2016-certified company supplies catheters, balloons, steerable systems, nitinol technologies, electromagnetic sensors, and complex assemblies.

Read further here: https://www.prnewswire.com/news-releases/quasar-medical-acquires-nitinol-design-and-development-center-302839603.html

Norman Noble adds engineering design services for medical implants

Norman Noble, Inc., Highland Heights, Ohio, announced in February 2026 the addition of engineering design services to its medical-implant manufacturing portfolio. The new offering supports customers developing implantable devices that require advanced laser machining of nitinol, cobalt-chromium, titanium, and other high-performance alloys, and lets device makers partner with Norman Noble at the earliest stages of product development.

Through the engineering design service, Norman Noble’s team works with customers on drawing specifications, design for manufacturability, prototyping strategy, and process development with the goal of moving from concept to validated prototype faster than is typical with sequential outsourcing. The capability builds on the company’s existing offerings in laser machining, athermal Noble STEALTH laser processing, Noble SynchroFlash, and Noble DryEPolish surface finishing — all of which are already used across the cardiovascular, structural heart, neurovascular, and orthopedic implant markets.

By adding upfront design support, Norman Noble strengthens its position as a contract development and manufacturing organization (CDMO) for complex implantable devices. The expansion reflects increasing customer demand for integrated end-to-end partners that can carry a device from early concept through validated production, particularly for nitinol implants where design choices and manufacturing methods are tightly coupled.

Norman Noble, Inc. is a privately held precision contract manufacturer headquartered in Highland Heights, Ohio. The company specializes in laser machining and finishing of nitinol and other implant-grade alloys, and supports the development and manufacture of finished medical implants for global medical device customers.

Read further here

Gore gains FDA approval for first deep venous stent indicated for the IVC and iliofemoral veins

W. L. Gore & Associates, Newark, Delaware, announced on January 6, 2026 that the U.S. Food and Drug Administration has approved the GORE VIABAHN FORTEGRA Venous Stent for the treatment of deep venous disease in the inferior vena cava (IVC), iliac, and iliofemoral veins. The device is the first stent approved in the United States for the IVC and iliofemoral indication, and previously received FDA Breakthrough Device designation.

The FORTEGRA Venous Stent (formerly the GORE VIAFORT Vascular Stent) consists of an open-structure, self-expanding wire-wound nitinol frame and an expanded polytetrafluoroethylene (ePTFE) polymer lattice. The combination is designed to balance conformability to the natural venous anatomy with compression resistance throughout the entire device length, while the wound nitinol architecture supports fracture resistance under the dynamic mechanical loading characteristic of large-vein anatomy.

Approval was supported by an international pivotal trial that evaluated 89 patients with deep venous disease across the IVC, iliac, and iliofemoral veins. The device met its primary safety and effectiveness endpoints and demonstrated patency, freedom from clinically driven reintervention, and safety performance consistent with a first-line venous stent indication.

W. L. Gore & Associates is a privately held global manufacturing company founded in 1958 and headquartered in Newark, Delaware. Its medical products division supplies cardiovascular, vascular, structural heart, and surgical solutions in more than 50 countries and has served the deep venous disease space through prior peripheral and arteriovenous platforms.

Read further here

Resonetics to Acquire Resolution Medical, Expanding Neuromodulation and Structural Heart Capabilities

Resonetics, Nashua, New Hampshire, announced that it has signed an agreement to acquire Resolution Medical, a medical device design and manufacturing firm headquartered in Fridley, Minnesota, with additional operations in the Netherlands. The transaction is expected to close in 2026, pending regulatory approvals.

The acquisition adds complementary capabilities in high-growth therapeutic markets including neuromodulation, structural heart, and interventional cardiology. Resolution Medical brings integrated design engineering, new product introduction, and cleanroom production capabilities for Class II and Class III devices, along with a team of more than 240 employees, including over 100 engineers.

“This acquisition will enhance our ability to deliver fully integrated solutions for customers in high-growth markets,” said Kevin Kelly, chief executive officer of Resonetics. The deal marks Resonetics’ third acquisition in the past 12 months as the company continues to broaden its medical device manufacturing platform.

Resonetics specializes in laser processing, nitinol components, and advanced manufacturing for the medical device industry.

Read further here

Squid inspires comfortable implants

Led by scientists at Case Western Reserve University, Cleveland, researchers turned to an unlikely model to make medical devices safer and more comfortable: a squid’s beak. Many medical implants require hard materials that have to connect to or pass through soft body tissue. This mechanical mismatch leads to problems such as skin breakdown at abdominal feeding tubes in stroke patients and where wires pass through the chest to power assistive heart pumps. Enter: the squid.

Continue reading

Norman Noble enhances laser welding capabilities for medical device manufacturing

Norman Noble, Highland Heights, Ohio, announced advancements in its laser welding technology to support the precise manufacturing needs of next-generation medical implants and devices. The company’s state-of-the-art fiber laser systems are engineered to deliver exceptional power and positioning accuracy, resulting in highly precise and repeatable welds.

The enhanced laser welding capabilities enable superior joint integrity for complex geometries, with optimized parameters for weld penetration, width, and positioning. These processes are rigorously developed and tested to meet stringent tensile and fatigue requirements for thin-walled and miniature components, while minimizing visual imperfections in the welds.

Jeff Miller, laser process development manager at Norman Noble, emphasized the company’s ability to weld various materials in intricate applications, such as Nitinol-to-Nitinol joints in orthopedic implants and platinum marker welding for stent-like devices. He highlighted the team’s expertise in creating custom solutions tailored to complex medical device manufacturing.

Norman Noble’s ongoing investment in laser technology, including custom fixturing to ensure alignment and repeatability, reinforces its position as a trusted partner for original equipment manufacturers requiring high-quality components in the medical sector.

Read further here. 

 

Get the latest on titanium brazing

An article by one of the leading authorities on titanium brazing – vetted and accepted for publication in the peer-reviewed ASM Handbook, Volume 6, Welding, Brazing, and Soldering – is now available online in digital form. “Brazing of Conventional Titanium Alloys,” a comprehensive, fact-filled survey by industry expert Alexander E. Shapiro, Ph.D., Titanium Brazing Inc., offers in-depth analysis and practical advice on how to braze commercially pure and alloyed titanium with itself as well as with other materials such as copper, stainless steel, carbon steel, ceramics, graphite, and titanium aluminide.

Continue reading

Researchers develop novel resin for 3D printing intraocular devices

Innovative resin for 3D printing intraocular lens (IOL) devices, developed by University of East Anglia researchers, could revolutionize cataract and refractive surgeries. This breakthrough enhances the production of eye implants, which are essential for people with cataracts whose natural lenses have clouded, affecting vision.

Historically, IOLs have been made from a variety of materials, including glass and silicone, although more recently, the industry has significantly evolved to predominantly use acrylic materials.

Currently hydrophilic and hydrophobic acrylic are the most commonly used materials due to their excellent optical clarity, flexibility, biocompatibility with the body and for their stability and safety within the eye.

Current methods of making IOLs use lathing and molding techniques. While these methods offer the production of well-engineered and high-optical quality devices, they also come with inherent limitations, particularly in terms of design complexity and customisation.

Dr. Aram Saeed said: “3D printing could significantly enhance the production of ocular devices, not only improving speed and precision in manufacturing but also enabling greater complexity and customization in design. Our proof-of-concept paper is the first in a series that will detail our developments in this area and set the stage for transforming eye care practices globally. Our work combines material science with healthcare technology and requires extensive know-how in developing these types of ocular devices. As we continue to publish our findings and share our advancements, we aim to be at the forefront of the industry, working with industrial partners and researchers worldwide to refine and enhance the technology.”

The study found that the 3D-printed lenses have good optical clarity, can be folded, and can be implanted into a human capsular bag.

Co-author Michael Wormstone, Emeritus Professor at UEA’s School of Biological Sciences, said: “If successful in further developments, this new technology could transform the industry by enabling portable manufacturing solutions, especially beneficial in remote and economically disadvantaged areas. It also has the potential to support the production of premium, customized lenses that could enhance surgical outcomes in more advanced healthcare settings.”

The team’s efforts have been recognized with the awarding of a United States patent assigned to UEA Enterprise Limited, a business entity of the university focused on fostering innovation and commercializing research.

The UEA researchers continue to work closely with industry partners to refine the technology. It is hoped that clinical trials could start in the next few years.

For more information: Current Eye Research

Copper’s Conductivity and Antimicrobial Properties Inspire Renewed Interest

There is a growing interest in copper’s antimicrobial benefits for surface applications to possibly reduce the spread of COVID-19. In this digital-first article from Advanced Materials & Processes, ASM International’s flagship magazine, Harold T. Michels, consultant and retired senior vice president, Copper Development Association, Manhasset, N.Y., details the antimicrobial features of copper and its alloys. Paired with his research is a review of the metal’s other properties, which make it suitable for a range of uses. With content based on the peer-reviewed, internationally revered ASM Specialty Handbook: Copper and Copper Alloys, this article provides vital information to consider when determining whether to use copper for an application.

Continue reading

This ultrasound sticker senses changing stiffness of deep internal organs

MIT engineers have developed a small ultrasound sticker that can monitor the stiffness of organs deep inside the body. The sticker, about the size of a postage stamp, can be worn on the skin and is designed to pick up on signs of disease, such as liver and kidney failure and the progression of solid tumors.

The team reports that the sensor can send sound waves through the skin and into the body, where the waves reflect off internal organs and back out to the sticker. The pattern of the reflected waves can be read as a signature of organ rigidity, which the sticker can measure and track.

“When some organs undergo disease, they can stiffen over time,” says the senior author of the paper, Xuanhe Zhao, professor of mechanical engineering at MIT. “With this wearable sticker, we can continuously monitor changes in rigidity over long periods of time, which is crucially important for early diagnosis of internal organ failure.”

The team has demonstrated that the sticker can continuously monitor the stiffness of organs over 48 hours and detect subtle changes that could signal the progression of disease. In preliminary experiments, the researchers found that the sticky sensor can detect early signs of acute liver failure in rats.

The engineers are working to adapt the design for use in humans. They envision that the sticker could be used in intensive care units (ICUs), where the low-profile sensors could continuously monitor patients who are recovering from organ transplants.

“We imagine that, just after a liver or kidney transplant, we could adhere this sticker to a patient and observe how the rigidity of the organ changes over days,” lead author Hsiao-Chuan Liu says. “If there is any early diagnosis of acute liver failure, doctors can immediately take action instead of waiting until the condition becomes severe.” Liu was a visiting scientist at MIT at the time of the study and is currently an assistant professor at the University of Southern California.

The study’s MIT co-authors include Xiaoyu Chen and Chonghe Wang, along with collaborators at USC.

Like our muscles, the tissues and organs in our body stiffen as we age. With certain diseases, stiffening organs can become more pronounced, signaling a potentially precipitous health decline. Clinicians currently have ways to measure the stiffness of organs such as the kidneys and liver using ultrasound elastography — a technique similar to ultrasound imaging, in which a technician manipulates a handheld probe or wand over the skin. The probe sends sound waves through the body, which cause internal organs to vibrate slightly and send waves out in return. The probe senses an organ’s induced vibrations, and the pattern of the vibrations can be translated into how wobbly or stiff the organ must be.

Ultrasound elastography is typically used in the ICU to monitor patients who have recently undergone an organ transplant. Technicians periodically check in on a patient shortly after surgery to quickly probe the new organ and look for signs of stiffening and potential acute failure or rejection.

“After organ transplantation, the first 72 hours is most crucial in the ICU,” says another senior author, Qifa Zhou, a professor at USC. “With traditional ultrasound, you need to hold a probe to the body. But you can’t do this continuously over the long term. Doctors might miss a crucial moment and realize too late that the organ is failing.”

The team realized that they might be able to provide a more continuous, wearable alternative. Their solution expands on an ultrasound sticker they previously developed to image deep tissues and organs.

“Our imaging sticker picked up on longitudinal waves, whereas this time we wanted to pick up shear waves, which will tell you the rigidity of the organ,” Zhao explains.

Existing ultrasound elastrography probes measure shear waves, or an organ’s vibration in response to sonic impulses. The faster a shear wave travels in the organ, the stiffer the organ is interpreted to be. (Think of the bounce-back of a water balloon compared to a soccer ball.)

The team looked to miniaturize ultrasound elastography to fit on a stamp-sized sticker. They also aimed to retain the same sensitivity of commercial hand-held probes, which typically incorporate about 128 piezoelectric transducers, each of which transforms an incoming electric field into outgoing sound waves.

“We used advanced fabrication techniques to cut small transducers from high-quality piezoelectric materials that allowed us to design miniaturized ultrasound stickers,” Zhou says.

The researchers precisely fabricated 128 miniature transducers that they incorporated onto a 25-millimeter-square chip. They lined the chip’s underside with an adhesive made from hydrogel — a sticky and stretchy material that is a mixture of water and polymer, which allows sound waves to travel into and out of the device almost without loss.

In preliminary experiments, the team tested the stiffness-sensing sticker in rats. They found that the stickers were able to take continuous measurements of liver stiffness over 48 hours. From the sticker’s collected data, the researchers observed clear and early signs of acute liver failure, which they later confirmed with tissue samples.

“Once liver goes into failure, the organ will increase in rigidity by multiple times,” Liu notes.

“You can go from a healthy liver as wobbly as a soft-boiled egg, to a diseased liver that is more like a hard-boiled egg,” Zhao adds. “And this sticker can pick up on those differences deep inside the body and provide an alert when organ failure occurs.”

The team is working with clinicians to adapt the sticker for use in patients recovering from organ transplants in the ICU. In that scenario, they don’t anticipate much change to the sticker’s current design, as it can be stuck to a patient’s skin, and any sound waves that it sends and receives can be delivered and collected by electronics that connect to the sticker, similar to electrodes and EKG machines in a doctor’s office.

“The real beauty of this system is that since it is now wearable, it would allow low-weight, conformable, and sustained monitoring over time,” says Shrike Zhang, an associate professor of medicine at Harvard Medical School and associate bioengineer at Brigham and Women’s Hospital, who was not involved with the study. “This would likely not only allow patients to suffer less while achieving prolonged, almost real-time monitoring of their disease progression, but also free trained hospital personnel to other important tasks.”

The researchers are also hoping to work the sticker into a more portable, self-enclosed version, where all its accompanying electronics and processing is miniaturized to fit into a slightly larger patch. Then, they envision that the sticker could be worn by patients at home, to continuously monitor conditions over longer periods, such as the progression of solid tumors, which are known to harden with severity.

“We believe this is a life-saving technology platform,” Zhao says. “In the future, we think that people can adhere a few stickers to their body to measure many vital signals, and image and track the health of major organs in the body.”

For more information: Science Advances

Image: A small ultrasound sticker, worn on the skin, can monitor the stiffness of organs deep inside the body. The MIT-developed sensor could detect signs of disease such as liver and kidney failure, and the progression of solid tumors.

Neural network based control for magnetic shape memory alloy actuator

Sophia University, Japan, researchers have developed a new control scheme for the magnetic shape memory alloy-based actuator (MSMA-BA) that improves its positioning accuracy.

While MSMA-BA is a crucial component for high-precision positioning systems due to its high precision, low energy consumption, and large stroke, its hysteresis is an intrinsic property that can negatively affect its positioning accuracy. The team proposed a multi meta-model approach that combines the nonlinear auto-regressive moving average with exogenous inputs (NARMAX) and Bouc–Wen (BW) models to describe the dynamic hysteresis of MSMA-BA.

A wavelet neural network (WNN) was used to construct the nonlinear function of the multi meta-model, while iterative learning control was combined with a WNN to improve convergence speed. The proposed iterative learning controller was tested on MSMA-BA, with experiments demonstrating the scheme’s validity. The study’s main contribution was the convergence analysis of the iteration learning controller with iteration-dependent uncertainties.

Read further here.

‘Robotic’ fabric changes shape, moves, supports loads

Yale University, Conn., researchers have developed robotic fabrics by integrating functional fibers into conventional textiles. Fabrics, with their interlocking fibers, tend to be breathable, lightweight, and highly compact materials. Rebecca Kramer-Bottiglio and colleagues explored the design of independently functioning fabric machines and developed a standalone platform for robotic fabrics.

Continue reading

Seisa Medical acquires ProtoQuick and Peridot

Seisa Medical, El Paso, Texas, has acquired Bay Area-based businesses ProtoQuick Inc. and Peridot Corporation. This will add expertise to Seisa’s plastics and metals capabilities while also expanding their global infrastructure for high-volume production of FDA Class II and Class III devices.

Continue reading